Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 9, 2022, LiqTech International, Inc. (the “Company”) and Alexander
J. Buehler, agreed to certain amendments of Mr. Buehler’s Interim CEO Agreement.
As previously announced, Fei Chen has begun her role as Chief Executive Officer
of the Company starting on September 12, 2022. Mr. Buehler has stepped down as
Interim CEO effective upon Ms. Chen’s assumption of the role, and therefore his
Interim CEO Agreement was to terminate. The Company and Mr. Buehler have agreed,
however, that Mr. Buehler should stay on full time for a short period to assist
with the transition and therefore his Interim CEO Agreement will now terminate
on September 30, 2022.
Additionally, Mr. Buehler, who continues to serve on the board of directors of
the Company, has agreed to provide additional CEO transition services from
October 1, 2022 through November 11, 2022. As compensation for such services,
the Company will issue Mr. Buehler $47,753 of restricted stock units of the
Item 7.01 Regulation FD Disclosure.
LiqTech International, Inc. (the “Company”) has made available an Investor
Presentation, which is attached to this Current Report on Form 8-K as Exhibit
99.1 and incorporated herein by reference.
On September 13, 2022, the Company also issued a press release regarding its
stated annual guidance for fiscal 2022, which is attached to this Current Report
on Form 8-K as Exhibit 99.2 and incorporated herein by reference.
The information contained in this Item 7.01 and in the accompanying
Exhibits 99.1 and 99.2 hereto is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to liabilities under that Section and
shall not be deemed to be incorporated by reference in any filing of the Company
under the Securities Act of 1933, as amended, or the Exchange Act, except as
expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Exhibit Title or Description 99.1 Investor Presentation 99.2 Press Release dated September 13, 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses